BBA
KNSA icon

Baader Bank Aktiengesellschaft’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
+5,000
New +$259K 0.02% 367
2025
Q4 		– Sell
-9,040
Closed -$351K – 536
2025
Q3 		$351K Buy
+9,040
New +$294K 0.02% 376

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Baader Bank Aktiengesellschaft's KNSA Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 5,000 shares worth $320K. The stake represents 0.02% of the portfolio and ranks #367 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in KNSA as recently as Q3 2025.

Baader Bank Aktiengesellschaft first reported a position in KNSA in Q3 2025 and has held it in 2 quarters since. The position peaked at $351K in Q3 2025. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 5,000 shares of Kiniksa Pharmaceuticals worth $320K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Baader Bank Aktiengesellschaft position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.02% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #367 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Baader Bank Aktiengesellschaft's Kiniksa Pharmaceuticals position peaked at $351K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.